3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
257
Carcinoma, Intraductal, Noninfiltrating
24
Breast Carcinoma In Situ
21
Neoplasms
12
Neoplasm Metastasis
12
Breast Neoplasms, Male
12
Ovarian Neoplasms
10
Inflammatory Breast Neoplasms
7
Glioblastoma
6
Prostatic Neoplasms
5
Endometrial Neoplasms
5
Central Nervous System Neoplasms
5
Gliosarcoma
4
Fallopian Tube Neoplasms
4
Breast Cancer Female
4
Brain Neoplasms
4
Glioma
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Ductal, Breast
3
Breast Diseases
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Medulloblastoma
2
Liver Neoplasms
2
Infertility
2
Interventions
Clomiphene
11
Metformin
10
Letrozole
3
Inositol
3
Medroxyprogesterone Acetate
2
Glycoprotein Hormones, alpha Subunit
2
Folic Acid
2
Chorionic Gonadotropin
2
salicylsalicylic acid
1
maltodextrin
1
Vitamin D
1
Tamoxifen
1
Sodium Salicylate
1
Raloxifene Hydrochloride
1
Progestins
1
Progesterone
1
Nimodipine
1
Lactalbumin
1
Inulin
1
Flutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anovulation
×
Tamoxifen
×
Clear all
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled